LRRK2 and Parkinson disease: When applied to a multicenter cohort of 120 LRRK2 mutation carriers (first-degree relatives of LRRK2 PD patients), of whom only 10 converted to PD over 5 years, the cut-off for prodromal PD status yielded a PPV of 47%–67% [38].